Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

QED Therapeutics

QED Therapeutics is a biotechnology company focused on precision medicine for FGFR-driven disorders.
2018
11-50
Palo Alto, California, United States

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

65.M

Last Funding Amount

65.M

Last Funding Date

30-01-2018

Lead Investors

BridgeBio

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information